JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
5. KRYSTAL-12 Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation.
Slideshow
Share
Sign in
The version of the browser you are using is no longer supported. Please upgrade to a
supported browser
.
Dismiss
File
Edit
View
Help
Accessibility
Debug
Unsaved changes to Drive
Accessibility
View only
Rec
HTML view of the presentation